Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Circulation

• Publication date

  2008-03-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.107.722827PMID 18347221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

  2007cited by this paper
• First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers

  2007cited by this paper
• Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review

  2007cited by this paper
• ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

  2007cited by this paper
• Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress.

  2006cited by this paper
• Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome.

  2006cited by this paper
• von Willebrand factor, endothelial dysfunction, and cardiovascular disease

  2006cited by this paper
• Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS

  2006cited by this paper
• Co‐localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction

  2006cited by this paper
• Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction.

  2006cited by this paper
• Reduced von Willebrand factor‐cleaving protease (ADAMTS13) activity in acute myocardial infarction

  2006cited by this paper
• Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.

  2006cited by this paper
• Extensive coronary thrombosis in thrombotic-thrombocytopenic purpura.

  2006cited by this paper
• Building oligonucleotide therapeutics using non-natural chemistries.

  2006cited by this paper
• Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.

  2006cited by this paper
• Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.

  2006cited by this paper
• Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.

  2006cited by this paper
• CLINICAL RESEARCH Interventional Cardiology Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention Insights Into the STRATEGY Study

  2006cited by this paper
• Laboratory identification of von Willebrand disease: technical and scientific perspectives.

  2006cited by this paper
• Aptamer therapeutics advance.

  2006cited by this paper
• Arterial and venous thrombosis in patients with von Willebrand’s disease: A critical review of the literature

  2006cited by this paper
• Time course of release of inflammatory markers after coronary stenting: comparison between bare metal stent and sirolimus-eluting stent

  2005cited by this paper
• Activation-independent platelet adhesion and aggregation under elevated shear stress.

  2005cited by this paper
• The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency

  2005cited by this paper
• Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.

  2005cited by this paper
• Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.

  2005cited by this paper
• Cardiogenic shock due to thrombotic thrombocytopenic purpura

  2004cited by this paper
• ABO locus O1 allele and risk of myocardial infarction

  2004cited by this paper
• Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction

  2004cited by this paper
• Prospective Evaluation of von Willebrand Factor Release After Multiple and Single Stenting

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study

  2004cited by this paper
• Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.

  2003cited by this paper
• Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts Mortality

  2003cited by this paper
• Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation

  2003cited by this paper
• Different effects of various anti‐GPIIb‐IIIa agents on shear‐induced platelet activation and expression of procoagulant activity

  2003cited by this paper
• Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

  2003cited by this paper
• Thrombosis and Hemorrhage

  2002cited by this paper
• Processing of von Willebrand factor by ADAMTS-13.

  2002cited by this paper
• Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarction.

  2002cited by this paper
• ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

  2002cited by this paper
• Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty: Real-Time Grading of Microvascular Reperfusion and Prediction of Early and Late Recovery of Left Ventricular Function

  2002cited by this paper
• Pharmacokinetics and Pharmacodynamics of AJW200, a Humanized Monoclonal Antibody to von Willebrand Factor, in Monkeys

  2002cited by this paper
• Effect of a humanized monoclonal antibody to von Willebrand factor in a canine model of coronary arterial thrombosis.

  2002cited by this paper
• Inflammatory cytokine release in patients with unstable angina after coronary angioplasty.

  2002cited by this paper
• Myocardial infarction/injury is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University experience.

  2002cited by this paper
• von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

  2002cited by this paper
• Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

  2001cited by this paper
• Tissue Distribution of Factor VIII Gene Expression In Vivo – A Closer Look

  2001cited by this paper
• Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction.

  2001cited by this paper
• Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.

  2000cited by this paper
• Anti-Human von Willebrand Factor Monoclonal Antibody AJvW-2 Prevents Thrombus Deposition and Neointima Formation After Balloon Injury in Guinea Pigs

  2000cited by this paper
• A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patients.

  2000cited by this paper
• Interaction of von Willebrand Factor Domain A1 with Platelet Glycoprotein Ibα-(1–289)

  2000cited by this paper
• Partial inhibition of nitric oxide synthase primes the stimulated pathway of vWF-secretion in man.

  2000cited by this paper
• A rapid method to visualize von willebrand factor multimers by using agarose gel electrophoresis, immunolocalization and luminographic detection.

  2000cited by this paper
• Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• A pilot study of streptokinase‐induced endothelial injury and platelet activation following acute myocardial infarction

  2000cited by this paper
• Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction.

  2000cited by this paper
• Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.

  2000cited by this paper
• Plasma Concentration of von Willebrand Factor in Acute Myocardial Infarction

  2000cited by this paper
• Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention.

  2000cited by this paper
• AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes.

  1999cited by this paper
• Enhanced shear-induced platelet aggregation in acute myocardial infarction.

  1999cited by this paper
• Massive myocardial necrosis in thrombotic thrombocytopenic purpura: a case report and review of the literature.

  1999cited by this paper
• Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study

  1999cited by this paper
• Collagen-bound von Willebrand Factor Has Reduced Affinity for Factor VIII*

  1999cited by this paper
• Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.

  1999cited by this paper
• Biochemistry and genetics of von Willebrand factor.

  1998cited by this paper
• Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen.

  1998cited by this paper
• Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

  1998cited by this paper
• Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex.

  1998cited by this paper
• Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.

  1998cited by this paper
• High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

  1998cited by this paper
• Antagonism of vWF Inhibits both Injury Induced Arterial and Venous Thrombosis in the Hamster

  1998cited by this paper
• Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc gamma RII receptor-mediated platelet activation.

  1998cited by this paper
• Increased levels of soluble P-selectin in hypercholesterolemic patients.

  1998cited by this paper
• von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  1998cited by this paper
• Effects of Integrelin on platelet function in flow models of arterial thrombosis.

  1997cited by this paper
• Partial Blockade of Nitric Oxide Synthase Blunts the Exercise-induced Increase of von Willebrand Factor Antigen and of Factor VIII in Man

  1997cited by this paper
• Anti‐thrombotic effects and bleeding risk of AJvW‐2, a monoclonal antibody against human von Willebrand factor

  1997cited by this paper
• Acute myocardial infarction plasma augments platelet thrombus growth in high shear rates.

  1997cited by this paper
• Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.

  1997cited by this paper
• Plasma Derived von Willebrand Factor Preparations: Collagen Binding and Ristocetin Cofactor Activities

  1997cited by this paper
• von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

  1997cited by this paper
• Treatment of von Willebrand's disease

  1997cited by this paper
• Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.

  1997cited by this paper
• Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

  1997cited by this paper
• Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina.

  1997cited by this paper
• Heparins designed to specifically inhibit platelet interactions with von Willebrand factor.

  1996cited by this paper
• Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

  1996cited by this paper
• Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

  1996cited by this paper
• Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.

  1996cited by this paper
• Platelet von Willebrand factor in inherited and acquired bleeding disorders.

  1995cited by this paper
• Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Abolition of Cyclic Flow Variations in Stenosed, Endothelium‐Injured Coronary Arteries in Nonhuman Primates With a Peptide Fragment (VCL) Derived From Human Plasma von Willebrand Factor–Glycoprotein Ib Binding Domain

  1994cited by this paper
• Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris.

  1994cited by this paper
• Factor VIII, ABO blood group and the incidence of ischaemic heart disease

  1994cited by this paper

• Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease

  2026cites this paper
• RAB5C Increases Endothelial Release of VWF by Regulating Vesicle Trafficking.

  2026cites this paper
• Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotype

  2026cites this paper
• Analysis of Associated Risk Factors for Perioperative Blood Loss in Total Hip Arthroplasty

  2025cites this paper
• Pharmacotherapeutic options for coronary thrombosis treatment: where are we today?

  2025cites this paper
• Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study.

  2025cites this paper
• RalB uncoupling from exocyst is required for endothelial Weibel-Palade body exocytosis.

  2025cites this paper
• Correlations between human alveolar macrophage particulate matter load, air pollution particulate matter levels, and systemic inflammation markers in Mexico City

  2025cites this paper
• Long-Term Thrombotic Events in Patients with Myocardial Infarction: Proteomic Analysis of Platelets and Plasma Combined with Hemostasis Assessment.

  2025cites this paper
• Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes

  2025cites this paper
• Predictive value of the average three-vessel microvascular resistance in patients with non-ST-segment elevation myocardial infarction after percutaneous coronary intervention.

  2025cites this paper
• The Association of Elevated Factor VIII and von Willebrand Factor (vWF) Levels with SYNTAX Score in Patients with Chronic Coronary Syndrome

  2025cites this paper
• Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases

  2025cites this paper
• Von Willebrand factor and JAK2V617F variant allele frequency predict thrombosis and bleeding in patients with myeloproliferative neoplasms

  2025cites this paper
• Intercellular pathways of cancer treatment-related cardiotoxicity and their therapeutic implications: The paradigm of radiotherapy.

  2024cites this paper
• Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells

  2024cites this paper
• Obesity Is Associated With Higher Levels of Circulating Cytokines Involved in the Development of Cardiovascular Disease in People Living With HIV

  2024cites this paper
• A cross-sectional study of the association between blood cadmium and mortality among adults with myocardial infarction

  2024cites this paper
• Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

  2024cites this paper
• Coronary microthrombi in the failing human heart: the role of von Willebrand factor and PECAM-1

  2024cites this paper
• Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights

  2024cites this paper
• The Association between Coagulation and Atrial Fibrillation

  2024cites this paper
• von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.

  2024cites this paper
• Haemostatic response to different types of exercise training in patients with atherosclerotic vascular disease

  2024cites this paper
• Myosin-1C augments endothelial secretion of von Willebrand factor by linking contractile actomyosin machinery to the plasma membrane

  2024cites this paper
• RalB uncoupled exocyst mediates endothelial Weibel-Palade body exocytosis

  2024cites this paper
• Acute effects of high intensity interval training versus moderate intensity continuous training on haemostasis in patients with coronary artery disease

  2024cites this paper
• Blood coagulation in Prediabetes clusters–impact on all-cause mortality in individuals undergoing coronary angiography

  2024cites this paper
• Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF.

  2024cites this paper
• Von Willebrand factor: a possible biomarker for disease activity in vasculitis

  2024cites this paper
• Exploring the role of testosterone upon adiposity and cardiovascular risk markers in men with severe obesity

  2024cites this paper
• N-Acetylcysteine to Reduce Mortality for Patients Requiring Cardiac Catheterization or Cardiac Surgery: A Systematic Review and Meta-analysis

  2024cites this paper
• SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis

  2023cites this paper
• Feasibility of detecting snake envenomation biomarkers from dried blood spots

  2023cites this paper
• Von Willebrand factor is an independent predictor of short‐term mortality in acutely ill patients with cirrhosis

  2023cites this paper
• Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance

  2023cites this paper
• Methylomic, Proteomic, and Metabolomic Correlates of Traffic-Related Air Pollution in the Context of Cardiorespiratory Health: A Systematic Review, Pathway Analysis, and Network Analysis

  2023cites this paper
• Vascular Damage and Glycometabolic Control in Older Patients with Type 2 Diabetes

  2023cites this paper
• Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature

  2023cites this paper
• accom-APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

  2023cites this paper
• Aging Is Associated With Organ-Specific Alterations in the Level and Expression Pattern of von Willebrand Factor

  2023cites this paper
• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients

  2023cites this paper
• Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa.

  2023cites this paper
• Coronary artery bypass graft in a patient with Von Willebrand disease type 1

  2023cites this paper
• Blood group and ischemic stroke, myocardial infarction, and peripheral vascular disease: A meta-analysis of over 145,000 cases and 2,000,000 controls.

  2023cites this paper
• Comparative Study of the Myocardium of Patients from Four COVID-19 Waves

  2023cites this paper
• Preventing Cardiogenic Thromboembolism in Cats: Literature Gaps, Rational Recommendations, and Future Therapies.

  2023cites this paper
• Methylomic, proteomic, and metabolomic correlates of traffic-related air pollution: A systematic review, pathway analysis, and network analysis relating traffic-related air pollution to subclinical and clinical cardiorespiratory outcomes

  2023cites this paper
• Systematic review and meta-analysis of retinal microvascular caliber in bipolar disorder, major depressive disorder, and schizophrenia.

  2023cites this paper
• Effect of far-infrared radiation therapy on von Willebrand factor in patients with chronic kidney disease

  2023cites this paper
• Butein Ameliorates Chronic Stress Induced Atherosclerosis via Targeting Anti-inflammatory, Anti-fibrotic and BDNF Pathways.

  2023cites this paper
• Association of Genetic and Allelic Variants of Von Willebrand Factor (VWF), Glutathione S-Transferase and Tumor Necrosis Factor Alpha with Ischemic Stroke Susceptibility and Progression in the Saudi Population

  2023cites this paper
• Lower levels of vWF are associated with lower risk of cardiovascular disease

  2022cites this paper
• Association between short-term exposure to ambient air pollution and biomarkers of coagulation: A systematic review and meta-analysis.

  2022cites this paper
• Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke

  2022cites this paper
• Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease

  2022cites this paper
• Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor.

  2022cites this paper
• Proteomic Profiling of Plasma Biomarkers Associated With Return to Sport Following Concussion: Findings From the NCAA and Department of Defense CARE Consortium

  2022cites this paper
• Extracellular Vesicles as an Index for Endothelial Injury and Cardiac Dysfunction in a Rodent Model of GDM

  2022cites this paper
• APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

  2022cites this paper
• Effect of Low High-Density Lipoprotein Level on Endothelial Activation and Prothrombotic Processes in Coronary Artery Disease—A Pilot Study

  2022cites this paper
• Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion.

  2022cites this paper
• Blood-based and Imaging Biomarkers of Atherosclerosis.

  2022cites this paper
• Alteration of plasma von Willebrand factor in the treatment of retinal vein occlusion with cystoid macular edema

  2022cites this paper
• The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion.

  2022cites this paper
• The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis

  2022cites this paper
• Synopsis of Biomarkers of Atheromatous Plaque Formation, Rupture and Thrombosis in the Diagnosis of Acute Coronary Syndromes

  2022cites this paper
• Tissue dynamics of von Willebrand factor characterized by a novel fluorescent protein–von Willebrand factor chimera

  2021cites this paper
• MicroRNA-320a-3p Signatures as a Satisfactory Predictor of Acute Coronary Syndrome and Attenuates Inflammation by Targeting X-Linked Inhibitor of Apoptosis Protein

  2021cites this paper
• [Morphological and Molecular-Biological Changes in the Coronary Arteries after Stenting].

  2021cites this paper
• Proteomic Signature of Dysfunctional Circulating Endothelial Colony‐Forming Cells of Young Adults

  2021cites this paper
• Role of von Willebrand factor in venous thromboembolic disease

  2021cites this paper
• Hypertriglyceridemic Waist in Patients with Type 2 Diabetes: Its Relationship to Selected Markers of Vascular Damage

  2021cites this paper
• Endothelial Dysfunction and Systemic Inflammation in the Pathogenesis and Progression of Portal Hypertension

  2021cites this paper
• Global REACH 2018: Influence of excessive erythrocytosis on coagulation and fibrinolytic factors in Andean highlanders

  2021cites this paper
• Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy

  2021cites this paper
• Perspectives of Aptamers for Medical Applications

  2021cites this paper
• The hemostatic parameters in pregnant women with different types of diabetes mellitus

  2021cites this paper
• Level of von Willebrand factor to assess the occurrence and prognosis of acute myocardial infarction.

  2021cites this paper
• Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort

  2021cites this paper
• Dimethyl Itaconate-Loaded Nanofibers Rewrite Macrophage Polarization, Reduce Inflammation, and Enhance Repair of Myocardic Infarction.

  2021cites this paper
• Genetic Contributions to Early and Late Onset Ischemic Stroke

  2021cites this paper
• The effects of submaximal exercise and cold exposure on blood coagulation parameters in coronary artery disease patients

  2021cites this paper
• Drug delivery systems for cardiovascular ailments

  2021cites this paper
• In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα

  2021cites this paper
• Endothelial Dysfunction and Its Clinical Implications

  2021cites this paper
• The role of platelets in the pathogenesis of atherosclerosis

  2021cites this paper
• Association between exposure to different stone aggregates from asphalt and blood coagulability: A human exposure chamber study.

  2021cites this paper
• Lifelong dietary omega-3 fatty acid suppresses thrombotic potential through gut microbiota alteration in aged mice

  2021cites this paper
• Molecular Aspects of Pathophysiology of Platelet Receptors

  2020cites this paper
• Proteolysis of Von Willebrand Factor Influences Inflammatory Endothelial Activation and Vascular Compliance in Atherosclerosis

  2020cites this paper
• Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases

  2020cites this paper
• Exploration biologique de la fonction endothéliale

  2020cites this paper
• von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo

  2020cites this paper
• Factors Affecting the Formation and Treatment of Thrombosis by Natural and Synthetic Compounds

  2020cites this paper
• Short-term PM2.5 exposure and circulating von Willebrand factor level: a meta-analysis.

  2020cites this paper
• Impact of Von Willebrand Factor on Bacterial Pathogenesis

  2020cites this paper
• The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment

  2020cites this paper
• Platelet activation via dynamic conformational changes of von Willebrand factor under shear

  2020cites this paper
• Novel Biomarkers, ST‐Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention

  2020cites this paper